40 related articles for article (PubMed ID: 38695532)
1. Tumor-derived nanovesicles enhance cancer synergistic chemo-immunotherapy by promoting cGAS/STING pathway activation and immunogenetic cell death.
Guo Y; Qian R; Li Z; Lv T; Yang C; Li W; Pan T; Hou X; Wang Z
Life Sci; 2024 Jul; 348():122687. PubMed ID: 38718856
[TBL] [Abstract][Full Text] [Related]
2. Outer membrane vesicle-wrapped manganese nanoreactor for augmenting cancer metalloimmunotherapy through hypoxia attenuation and immune stimulation.
Luo S; Yang Y; Chen L; Kannan PR; Yang W; Zhang Y; Zhao R; Liu X; Li Y; Kong X
Acta Biomater; 2024 Jun; 181():402-414. PubMed ID: 38734282
[TBL] [Abstract][Full Text] [Related]
3. Potentiating Immunogenic Cell Death in Cold Tumor with Functional Living Materials of FeAu-Methylene Blue Composites.
Wang T; Wang Y; Liu T; Yu F; Liu L; Xiong H; Xu W; Fan X; Liu X; Jiang H; Zhang H; Wang X
Adv Healthc Mater; 2024 Jun; 13(14):e2302767. PubMed ID: 38381808
[TBL] [Abstract][Full Text] [Related]
4. Transformable Supramolecular Self-Assembled Peptides for Cascade Self-Enhanced Ferroptosis Primed Cancer Immunotherapy.
Wang H; Jiao D; Feng D; Liu Q; Huang Y; Hou J; Ding D; Zhang W
Adv Mater; 2024 May; 36(21):e2311733. PubMed ID: 38339920
[TBL] [Abstract][Full Text] [Related]
5. Emerging role of immunogenic cell death in cancer immunotherapy.
Arimoto KI; Miyauchi S; Liu M; Zhang DE
Front Immunol; 2024; 15():1390263. PubMed ID: 38799433
[TBL] [Abstract][Full Text] [Related]
6. Inhalable metal-organic framework-mediated cuproptosis combined with PD-L1 checkpoint blockade for lung metastasis synergistic immunotherapy.
Yan C; Liu Y; Zhao G; Yang H; Lv H; Li G; Li Y; Fu Y; Sun F; Feng Y; Li Y; Zhao Z
Acta Pharm Sin B; 2024 May; 14(5):2281-2297. PubMed ID: 38799628
[TBL] [Abstract][Full Text] [Related]
7. Nanoparticle Retinoic Acid-Inducible Gene I Agonist for Cancer Immunotherapy.
Wang-Bishop L; Wehbe M; Pastora LE; Yang J; Kimmel BR; Garland KM; Becker KW; Carson CS; Roth EW; Gibson-Corley KN; Ulkoski D; Krishnamurthy V; Fedorova O; Richmond A; Pyle AM; Wilson JT
ACS Nano; 2024 May; 18(18):11631-11643. PubMed ID: 38652829
[TBL] [Abstract][Full Text] [Related]
8. Branched glycopolymer prodrug-derived nanoassembly combined with a STING agonist activates an immuno-supportive status to boost anti-PD-L1 antibody therapy.
Li Z; Zhang Q; Li Z; Ren L; Pan D; Gong Q; Gu Z; Cai H; Luo K
Acta Pharm Sin B; 2024 May; 14(5):2194-2209. PubMed ID: 38799622
[TBL] [Abstract][Full Text] [Related]
9. Combination of MHI148 Targeted Photodynamic Therapy and STING Activation Inhibits Tumor Metastasis and Recurrence.
Yu H; Chen Q; Zheng M; Wang R; Wang H; Cheng L; Hu Y; Dai M; Du C; Luo W; Tan M; Cao Y; Guo Y; Ran H
ACS Appl Mater Interfaces; 2024 May; ():. PubMed ID: 38813586
[TBL] [Abstract][Full Text] [Related]
10. Activable Nano-Immunomodulator Assembled from π-Extended Naphthalenediimide for Precision Photothermal Immunotherapy.
Zhong W; Yuan W; Chen Y; Ma Z; Ma M; Tan BSN; Yang J; Zhao Y
Angew Chem Int Ed Engl; 2024 Jun; 63(23):e202401250. PubMed ID: 38576254
[TBL] [Abstract][Full Text] [Related]
11. Manganese oxide-constructed multifunctional biomimetic nanovaccine for robust tumor-specific T cell priming and chemodynamic therapy.
Li T; Chen G; Lin L; Li B; Wang X; Chen Y; Huang W; Cai M; Xiao Z; Shuai X; Zhu K
Biomaterials; 2024 Sep; 309():122626. PubMed ID: 38795524
[TBL] [Abstract][Full Text] [Related]
12. Ultrasound-visible engineered bacteria for tumor chemo-immunotherapy.
Yang Y; Wang Y; Zeng F; Chen Y; Chen Z; Yan F
Cell Rep Med; 2024 May; 5(5):101512. PubMed ID: 38640931
[TBL] [Abstract][Full Text] [Related]
13.
Qian Z; Zhang Z; Cen L; Ke Y; Shao J; Tian M; Liu B
J Biomed Res; 2024 May; ():1-13. PubMed ID: 38807377
[TBL] [Abstract][Full Text] [Related]
14. A NIR-Light-Activated and Lysosomal-Targeted Pt (II) Metallacycle for Highly Potent Evoking of Immunogenic Cell Death that Potentiates Cancer Immunotherapy of Deep-Seated Tumors.
Li C; Tu L; Xu Y; Li M; Du J; Stang PJ; Sun Y; Sun Y
Angew Chem Int Ed Engl; 2024 May; ():e202406392. PubMed ID: 38775364
[TBL] [Abstract][Full Text] [Related]
15. Syringeable Near-Infrared Light-Activated In Situ Immunogenic Hydrogel Boosts the Cancer-Immunity Cycle to Enhance Anticancer Immunity.
Fu Y; Zhu X; Ren L; Wan J; Wang H
ACS Nano; 2024 May; ():. PubMed ID: 38809421
[TBL] [Abstract][Full Text] [Related]
16. Immunogenic cell stress and injury versus immunogenic cell death: implications for improving cancer treatment with immune checkpoint blockade.
Sriram G; Emmons TR; Milling LE; Irvine DJ; Yaffe MB
Mol Cell Oncol; 2022; 9(1):2039038. PubMed ID: 35402699
[TBL] [Abstract][Full Text] [Related]
17. Genetically Edited Cascade Nanozymes for Cancer Immunotherapy.
Zhang J; Pan Y; Liu L; Xu Y; Zhao C; Liu W; Rao L
ACS Nano; 2024 May; 18(19):12295-12310. PubMed ID: 38695532
[TBL] [Abstract][Full Text] [Related]
18. A homologous-targeting cGAS-STING agonist multimodally activates dendritic cells for enhanced cancer immunotherapy.
Wang P; Wang Y; Li H; Wang M; Wang Y; Wang X; Ran L; Xin H; Ma J; Tian G; Gao W; Zhang G
Acta Biomater; 2024 Mar; 177():400-413. PubMed ID: 38336268
[TBL] [Abstract][Full Text] [Related]
19. Manganese is critical for antitumor immune responses via cGAS-STING and improves the efficacy of clinical immunotherapy.
Lv M; Chen M; Zhang R; Zhang W; Wang C; Zhang Y; Wei X; Guan Y; Liu J; Feng K; Jing M; Wang X; Liu YC; Mei Q; Han W; Jiang Z
Cell Res; 2020 Nov; 30(11):966-979. PubMed ID: 32839553
[TBL] [Abstract][Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]
